The complete low testosterone testing guide — What to order, when to test, and how to read results

A complete low testosterone test starts with persistent symptoms, a fasting morning testosterone blood test drawn from 07:00 to 11:00, and results interpreted against 350 ng/dL for total testosterone and 100 pg/mL for free testosterone when symptoms persist. A low number alone is not a diagnosis, and symptoms alone are not enough either. The most important add on tests are LH and FSH, because they show whether the problem is in the testes or in brain signaling, which directly changes treatment.

Key takeaways

• A proper low testosterone test is a fasting morning blood draw done from 07:00 to 11:00, and low or borderline results should be confirmed on a separate morning rather than diagnosed from one random sample.^{[1] [2]}
• Results below 350 ng/dL for total testosterone and below 100 pg/mL for free testosterone matter clinically only when symptoms persist, because male hypogonadism is a syndrome, not a lab number alone.^{[2] [3] [7]}
• For a free testosterone test, direct analog immunoassays should be avoided. Equilibrium dialysis paired with LC-MS/MS is the gold standard and the most trustworthy method for measuring the active fraction.^{[2] [9] [10]}
• An LH FSH testosterone test is mandatory. High LH plus low testosterone points to primary hypogonadism, while low or normal LH plus low testosterone points to secondary hypogonadism.^{[1] [2]}
• A complete testosterone testing guide also includes CBC, comprehensive metabolic panel, estradiol, PSA in men age 40 or older, and prolactin when low LH accompanies low testosterone or low sexual desire is the main complaint.^{[1] [2]}
• Clearer biochemical deficiency makes symptomatic treatment benefit more likely, while decisions become more uncertain as baseline total testosterone rises above 350 ng/dL unless free testosterone measured accurately is low.^[3]

Who should get a low testosterone test

Low testosterone testing should begin only after persistent symptoms or signs of hypogonadism have been identified and reversible suppressors, metabolic disease, and treatment contraindications have been reviewed.^{[1] [2] [3]}

Start with symptoms, not a random screen

According to the American Urological Association guideline, the first step in the diagnostic algorithm is not a lab order. It is a clinical assessment.^[1] Hypogonadism is the clinical syndrome of persistent symptoms plus biochemical testosterone deficiency. That is why a low testosterone test makes sense in men with suggestive sexual, physical, or energy related symptoms, but not as a stand alone screening number pulled from an unrelated panel.

This point matters because many men arrive with a single “low T” value from an unscheduled wellness draw and assume the diagnosis is already established. It is not. A low number without symptoms does not confirm disease, and symptoms without lab confirmation do not confirm it either. For the full definition of that syndrome, see clinical definition of low testosterone.

Review reversible suppressors and treatment context before labs

Before ordering a testosterone blood test, clinicians should document drugs and substances that can suppress testosterone production, along with obesity, metabolic syndrome, and diabetes. The reason is simple. These factors can lower testosterone through functional suppression rather than permanent gland failure. Functional hypogonadism is reversible suppression of the hormone axis caused by illness or metabolic stress rather than structural damage.

The same visit should also capture information that affects treatment decisions later, especially fertility plans, prostate risk assessment, and baseline hematocrit risk. In other words, how to test for low testosterone correctly starts before the needle touches skin. Good testing is not only about measuring testosterone. It is about establishing whether the result will be clinically meaningful and safe to act on.

When and how to do the testosterone blood test

A testosterone blood test should be drawn in the morning, in the fasting state, and never during acute illness because temporary suppression can mimic true hypogonadism.^{[1] [2]}

Why morning and fasting matter

The Endocrine Society guideline recommends morning testing because testosterone follows a daily rhythm, with the highest values early in the day.^[2] A sample drawn in mid afternoon can therefore understate the true baseline.

Fasting also improves consistency. Food intake can lower measured testosterone, which means a late breakfast draw is not equivalent to a fasting morning draw. For a man asking how to test for low testosterone properly, the practical answer is straightforward. Book the test between 07:00 and 11:00, arrive fasting, and use the same conditions if the test needs to be repeated.

Repeat testing matters because testosterone varies from day to day even in the same man, which is why one isolated value should be treated cautiously. If the first result is low or borderline and symptoms persist, confirm it with a second morning sample.

When not to test

Never use an acute illness draw to diagnose chronic testosterone deficiency. Fever, infection, surgery, severe sleep disruption, or other acute stressors can create transient functional hypogonadism that does not reflect baseline physiology. This is one of the most common reasons an unscheduled low testosterone test becomes misleading.

According to both major guidelines, the goal is to measure the man’s usual state, not his worst day.^{[1] [2]} If he is ill, wait until recovery and then repeat the testosterone blood test under proper fasting morning conditions.

Which assay makes a test trustworthy

The most trustworthy testosterone blood test uses LC-MS/MS for sex steroid measurement and equilibrium dialysis for the free testosterone test, because direct free testosterone immunoassays are inaccurate and should be avoided.^{[2] [9] [10]}

Why LC-MS/MS beats routine immunoassays

According to an Endocrine Society position statement, testosterone assays vary in accuracy, and routine immunoassays can introduce clinically important error, especially near the lower end where diagnostic decisions are made.^[9] LC-MS/MS identifies testosterone by molecular structure and is the most accurate method for sex steroid evaluation in modern clinical practice. That matters because the question is not whether a result is roughly close. The question is whether it is accurate enough to support a lifelong diagnosis or treatment decision.

At Veedma, we use Equilibrium Dialysis with LC-MS/MS to measure total and free testosterone so results can be interpreted against research grade evidence rather than the limitations of convenience testing. This is especially important when symptoms are convincing but a prior routine assay came back “normal.” For more on that scenario, see why your testosterone test came back normal.

Why the free testosterone test can change the answer

SHBG, or sex hormone binding globulin, is a liver made protein that binds testosterone tightly and reduces the free fraction available to tissues. Changes in SHBG can therefore make total testosterone less informative and can contribute to clinically relevant low free testosterone even when total testosterone does not look clearly low.

A 2016 Journal of Clinical Endocrinology and Metabolism analysis reported that men with normal total testosterone but low free testosterone still showed more hypogonadal signs and symptoms.^[7] This is the hidden deficiency problem. The total number may look acceptable, but the active fraction is not.

For that reason, this testosterone testing guide prioritizes the free testosterone test. If direct measurement is done, equilibrium dialysis is the gold standard. If a clinic offers only a direct analog free testosterone immunoassay, that result should not be trusted for diagnosis. Even the Endocrine Society states that direct free testosterone evaluation with these methods is not recommended and should be avoided.^{[2] [9]}

What to order in a complete low testosterone test

A complete low testosterone test panel includes total testosterone, a gold standard free testosterone test, LH, FSH, CBC, comprehensive metabolic panel, estradiol, and age appropriate PSA, with prolactin and other add ons used when the pattern suggests secondary disease or common mimics.^{[1] [2]}

Core labs that change diagnosis, safety, and treatment

This is the minimum diagnostic set that meaningfully affects interpretation, safety, and treatment selection. A testosterone blood test without LH and FSH is incomplete. A low testosterone test without CBC and metabolic panel is also incomplete, because treatment planning requires baseline hematocrit and metabolic context.

Conditional add ons that refine the workup

Prolactin is a pituitary hormone that can suppress GnRH and reduce LH output when it is elevated. Prolactin screening is strongly recommended when low testosterone appears alongside low LH, or when low sexual desire is a primary complaint.^{[1] [2]} Elevated prolactin can result from pituitary adenomas or medications such as antipsychotics and metoclopramide. Both are treatable causes that should be identified before TRT is started.

A thyroid panel is useful when symptoms suggest thyroid disease. Vitamin D is reasonable because deficiency is common and can contribute to low energy. A lipid panel is particularly useful in overweight men or those with metabolic risk, because insulin resistance and dyslipidemia frequently travel with functional testosterone suppression.

Some clinical clues should trigger extra caution. Headache, visual disturbance, or other signs of anterior pituitary deficiency should raise concern for a pituitary process rather than isolated testosterone deficiency. In those men, the right next step is not blind hormone replacement. It is endocrine evaluation guided by the lab pattern.

At Veedma, the initial men’s health workup covers more than 40 biomarkers, or we can review existing outside labs, including panels from services such as Function Health, to identify what is missing before any treatment decision is made.

How to read total and free testosterone results

Testosterone results should be read against symptoms first, then against biochemical thresholds, with 350 ng/dL used as a reliable total testosterone decision point and 100 pg/mL used by Veedma as a free testosterone decision threshold when symptoms persist.^{[3] [7]}

How to read total testosterone

The European style threshold used in this guide is 350 ng/dL. In practical terms, results below that level deserve serious attention when symptoms persist, while results above it require more caution and a closer look at free testosterone measured accurately before treatment is considered. Clinical benefit is generally less predictable as baseline total testosterone rises, especially when the biochemical picture is borderline rather than unequivocally low.

This is why “normal” is not always the end of the story. A man can sit above 350 ng/dL on total testosterone yet still be symptomatic because the free fraction is low.

How to read the free testosterone test

Free testosterone interpretation is more nuanced than total testosterone, but it is often more clinically useful because it can uncover deficiency that total testosterone alone may miss when binding conditions differ between men. ^[7]

Age specific percentile values are not presented here because a verifiable male free testosterone reference study using equilibrium dialysis with LC-MS/MS is not cited in this article.

The practical point is not a single percentile table. It is that method specific ranges matter, and a broad all age reference interval can miss clinically important low free testosterone in a symptomatic man.

At Veedma, we use 100 pg/mL as a decision threshold when symptoms persist. That threshold is designed to catch men whose total testosterone looks passable but whose active fraction is clearly reduced. If you are searching for how to test for low testosterone after being told your total result is normal, this is the place where the free testosterone test often changes the answer.

How LH and FSH change the treatment path

LH and FSH are mandatory in every diagnostic workup because they distinguish primary from secondary hypogonadism, and that distinction determines whether Enclomiphene or testosterone replacement makes clinical sense.^{[1] [2] [3]}

What high LH plus low testosterone means

LH, or luteinizing hormone, is the pituitary signal that tells the testes to make testosterone. FSH, or follicle stimulating hormone, is the pituitary signal that supports sperm production. When LH is high and testosterone is low, the brain is signaling correctly and the testes are not responding. That pattern is primary hypogonadism.

Primary hypogonadism generally means the testes are failing. Enclomiphene will not fix that, because the stimulation signal is already high. In that setting, TRT is the appropriate path. This is exactly why the LH FSH testosterone test is not optional. It answers the most important mechanistic question in the entire workup.

What low or normal LH plus low testosterone means

When LH is low or inappropriately normal while testosterone is low, the pattern is secondary hypogonadism. This is the more common real world scenario. The testes may still be capable of producing testosterone, but the signal from the brain is too weak. In men with LH below 8 mIU/mL, Enclomiphene is a strong first line candidate because it stimulates natural testosterone production, preserves spermatogenesis, and does not shut down the axis the way TRT does.

This is the difference between a fertility preserving stimulation strategy and lifelong replacement therapy that suppresses gonadotropins and sperm production. For a deeper discussion of the classification itself, see primary versus secondary hypogonadism.

According to the AUA and Endocrine Society approaches, any provider who prescribes testosterone without first checking LH and FSH is guessing at treatment.^{[1] [2]} At Veedma, this classification is built into a 40 plus biomarker diagnostic workup or into the review of existing outside labs. Men with secondary or functional patterns are typically considered for Enclomiphene first, while Testosterone Cypionate is reserved for men who truly need replacement.

Myth vs fact

Myth: A single low number diagnoses low testosterone

Fact: Diagnosis requires persistent symptoms plus biochemical confirmation, and low or borderline results should be repeated under the same fasting morning conditions before they are treated as definitive.^{[1] [2]}

Myth: Any time of day is fine for a testosterone blood test

Fact: Morning testing matters because testosterone peaks early in the day, and acute illness can cause transient functional suppression. The right test is a fasting morning draw from 07:00 to 11:00, not a random afternoon sample.^{[1] [2]}

Myth: Any free testosterone result is good enough

Fact: Direct analog free testosterone immunoassays are not reliable for diagnosis. The preferred free testosterone test uses equilibrium dialysis, ideally paired with LC-MS/MS.^{[2] [9] [10]}

Myth: Total testosterone alone tells you what treatment to use

Fact: The LH FSH testosterone test is what separates primary from secondary hypogonadism. High LH plus low testosterone points to testicular failure and TRT, while low or normal LH plus low testosterone points to secondary disease, where Enclomiphene may preserve fertility and restore natural production.^{[1] [2]}

Myth: A normal total testosterone rules out deficiency

Fact: Men with normal total testosterone can still have low free testosterone and typical hypogonadal symptoms. That is why a complete low testosterone test includes a high quality free testosterone measurement. ^[7]

Bottom line

The right way to answer the title question is this. Order a fasting morning testosterone blood test from 07:00 to 11:00, pair total testosterone with a gold standard free testosterone test, and always add LH and FSH before making a diagnosis or choosing treatment. Results below 350 ng/dL for total testosterone or 100 pg/mL for free testosterone matter only when symptoms persist, and LH plus FSH determine whether the next step is Enclomiphene or TRT. For the full diagnostic and treatment roadmap, see the Low Testosterone hub.

References

1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. The Journal of urology. 2018;200:423-432. PMID: 29601923
2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018;103:1715-1744. PMID: 29562364
3. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. The New England journal of medicine. 2010;363:123-35. PMID: 20554979
4. Incorrect source removed in revision; the discussion of SHBG and free testosterone now relies on guideline language and male symptom data cited elsewhere in the article.
5. Incorrect source removed in revision; morning testosterone testing in the article is supported by the guideline citations above.
6. Incorrect source removed in revision; repeat morning confirmation in the article is supported by the guideline citations above.
7. Antonio L, Wu FC, O’Neill TW, et al. Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone. The Journal of clinical endocrinology and metabolism. 2016;101:2647-57. PMID: 26909800
8. Incorrect source removed in revision; the article now uses more cautious language about expected benefit as baseline testosterone rises.
9. Rosner W, Auchus RJ, Azziz R, et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. The Journal of clinical endocrinology and metabolism. 2007;92:405-13. PMID: 17090633
10. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of clinical endocrinology and metabolism. 1999;84:3666-72. PMID: 10523012
11. Incorrect source removed in revision; age specific free testosterone percentile values are not presented without a verifiable male reference study.